[1]
Shichiri, K. et al. 2025. Immune Checkpoint Inhibition for Hepatocellular Carcinoma, Cholangiocarcinoma, and Combined Hepatocellular-Cholangiocarcinoma. World Journal of Oncology. 16, 3 (Jun. 2025), 243–253. DOI:https://doi.org/10.14740/wjon2571.